טפמטקו
merck serono ltd - tepotinib as hydrochloride hydrate - טבליות מצופות פילם - tepotinib as hydrochloride hydrate 225 mg - tepotinib
יוטירוקס 25 מקג
merck serono ltd - levothyroxine sodium - טבליה - levothyroxine sodium 25 mcg - levothyroxine sodium
גלוקופג' xr 1000 מג
merck serono ltd - metformin hydrochloride - טבליות בשחרור ממושך - metformin hydrochloride 1000 mg - metformin
גלוקופג' xr 500 מג
merck serono ltd - metformin hydrochloride - טבליות בשחרור ממושך - metformin hydrochloride 500 mg - metformin
גלוקופג' xr 750 מג
merck serono ltd - metformin hydrochloride - טבליות בשחרור ממושך - metformin hydrochloride 750 mg - metformin
surgical pruducts,orthopedic&patient hea
אסיא טכנולוגיות בע"מ - אחות - אביזרי ניתוח אורטופדיה מוצרי טיפול בחולה
רנוולה טבליות 800 מג
sanofi israel ltd - sevelamer carbonate anhydrous - טבליות מצופות פילם - sevelamer carbonate anhydrous 800 mg - sevelamer - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus ? 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.
קייליקס
j-c health care ltd - doxorubicin hydrochloride - liposome for infusion - doxorubicin hydrochloride 2.0 mg/ml - doxorubicin - doxorubicin - first or second line therapy of aids related kaposis sarcoma in patients with low cd 4 counts and extensive mucocutaneous or visceral disease the treatment of patients with metastatic carcinoma of the ovary who are refractory to both paclitaxel and platinium-based chemotherapy regimens and who may also be refractory to topotecan. refractory is defined as a patient having progressive disease while on treatment or within 6 months of completing treatmnt. as monotherapy for patients with metastatic breast cancer where there is an increased cardiac risk. in combination with bortezomib for the treatment of progressive multiplemyeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant.
מיוסט 50 מג
medison pharma ltd - doxorubicin hydrochloride - אבקה, מפזר וממס להכנת תרכיז לפיזור באינפוזיה - doxorubicin hydrochloride 50 mg vials - doxorubicin - doxorubicin - myocet, in combination with cyclophosphamide, is indicated for the first line treatment of metastatic breast cancer in women.